
Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

